Immuneering (IMRX) Amortization - Intangibles (2022 - 2026)
Immuneering (IMRX) recorded quarterly Amortization - Intangibles of $7317.0 in Q1 2026, little changed quarter-over-quarter from $7317.0 in Q4 2025, and little changed on a YoY basis from $7317.0 in Q1 2025.
Immuneering (IMRX) Amortization - Intangibles (2022 - 2026) Analysis & Trends
Immuneering's Amortization - Intangibles history runs 5 years deep, the most recent figure standing at $7317.0 for Q1 2026.
- In Q1 2026, Amortization - Intangibles changed 0.0% year-over-year to $7317.0; the TTM figure through Mar 2026 stood at $29268.0 (changed 0.0% YoY), while the FY2025 annual figure was $29267.0, changed 0.0% from the prior year.
- Amortization - Intangibles was $7317.0 for Q1 2026 at Immuneering, roughly flat from $7317.0 in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $8103.0 in Q1 2022 to a low of $7316.0 in Q4 2022.
- Historically, Amortization - Intangibles has averaged $7363.2 across 5 years, with a median of $7317.0 in 2022.
- Biggest YoY gain for Amortization - Intangibles was 0.01% in 2023; the steepest drop was 9.7% in 2023.
- A 5-year view of Amortization - Intangibles shows it stood at $7316.0 in 2022, then gained by 0.01% to $7317.0 in 2023, then changed by 0.0% to $7317.0 in 2024, then changed by 0.0% to $7317.0 in 2025, then changed by 0.0% to $7317.0 in 2026.
- The last three Amortization - Intangibles figures came in at $7317.0 (Q1 2026), $7317.0 (Q4 2025), and $7317.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,317.00 |
| Dec 31, 2025 | 7,317.00 |
| Sep 30, 2025 | 7,317.00 |
| Jun 30, 2025 | 7,317.00 |
| Mar 31, 2025 | 7,317.00 |
| Dec 31, 2024 | 7,317.00 |
| Sep 30, 2024 | 7,317.00 |
| Jun 30, 2024 | 7,317.00 |
| Mar 31, 2024 | 7,317.00 |
| Dec 31, 2023 | 7,317.00 |
| Sep 30, 2023 | 7,317.00 |
| Jun 30, 2023 | 7,317.00 |
| Mar 31, 2023 | 7,317.00 |
| Dec 31, 2022 | 7,316.00 |
| Sep 30, 2022 | 7,317.00 |
| Jun 30, 2022 | 7,317.00 |
| Mar 31, 2022 | 8,103.00 |